Medication Adherence and Patients' Characteristics in Chronic Diseases: A National Multi-Center Study

Huda Al-Noumani1, Maryam Al-Harrasi1, Jimmy Jose2

  • 1Sultan Qaboos University, Muscat, Oman.

Insights

Medication adherence in chronic diseases is crucial. Retired patients, those with COPD, and shorter disease duration (≤5 years) showed higher adherence, highlighting the need for personalized strategies.

Area of Science:

  • Public Health
  • Clinical Pharmacy
  • Chronic Disease Management

Background:

  • Chronic diseases pose a significant global health burden.
  • Medication adherence among patients with chronic conditions is often suboptimal.
  • Identifying factors influencing adherence is critical for effective management.

Purpose of the Study:

  • To investigate the relationship between patient characteristics and medication adherence in chronic diseases.
  • To identify specific patient demographics and conditions associated with varying adherence levels.

Main Methods:

  • A cross-sectional study involving 800 patients with chronic diseases.
  • Utilized the Adherence to Chronic Diseases Scale to assess medication adherence.
  • Employed descriptive statistics and logistic regression analysis to determine influencing factors.

Main Results:

  • 19.5% of patients exhibited low adherence, 45% medium, and 35.5% high adherence.
  • Logistic regression identified retired status (OR 0.496), COPD (OR 0.460), and disease duration ≤5 years (OR 1.554) as independent predictors of high adherence.
  • Observed mixed findings regarding the association between patient characteristics and medication adherence.

Conclusions:

  • Patient characteristics significantly influence medication adherence in chronic diseases.
  • Factors such as retirement, COPD diagnosis, and disease duration are key predictors.
  • Personalized approaches are necessary to improve medication adherence in clinical practice.

Related Concept Videos

Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
28
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
50
Factors Influencing Drug Absorption: Disease States and Pharmacology01:25

Factors Influencing Drug Absorption: Disease States and Pharmacology

Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
1.0K
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
126
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
44
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.7K